Literature DB >> 17083758

Definitions of remission for rheumatoid arthritis and review of selected clinical cohorts and randomised clinical trials for the rate of remission.

H Mäkinen1, P Hannonen, T Sokka.   

Abstract

Various definitions of remission in rheumatoid arthritis (RA) have been proposed. The ACR (American College of Rheumatology--formerly ARA, American Rheumatism Association) remission criteria are strict and include nonspecific symptoms such as fatigue. More recently remission according to the Disease Activity Index (DAS) and DAS28 has been described. However, patients who meet the DAS28 remission cut point of < 2.6 may nonetheless have tender and/or swollen joints. The ACR remission criteria are more rigorous than the requirement of DAS28 <2.6. Newer tools for evaluation of RA activity include the Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI), and cut points for remission according to these new indices have been defined. However, all available remission criteria may ignore important aspects of RA, including physical function and radiographic damage.

Entities:  

Mesh:

Year:  2006        PMID: 17083758

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  14 in total

1.  Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management.

Authors:  Lisa G Suter; Liana Fraenkel; R Scott Braithwaite
Journal:  Arch Intern Med       Date:  2011-04-11

2.  Profile and course of early rheumatoid arthritis in Morocco: a two-year follow-up study.

Authors:  Karima Benbouazza; Bahia Benchekroun; Hanan Rkain; Bouchra Amine; Fatiha Bzami; Leila Benbrahim; Ouafa Atouf; Malika Essakalli; Redouane Abouqal; Maxime Dougados; Najia Hajjaj-Hassouni
Journal:  BMC Musculoskelet Disord       Date:  2011-11-23       Impact factor: 2.362

3.  The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis.

Authors:  Fausto Salaffi; Maria Chiara Gerardi; Fabiola Atzeni; Alberto Batticciotto; Rossella Talotta; Antonella Draghessi; Marco Di Carlo; Piercarlo Sarzi-Puttini
Journal:  Rheumatol Int       Date:  2017-09-05       Impact factor: 2.631

Review 4.  Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference.

Authors:  Lilian H D van Tuyl; Steven C Vlad; David T Felson; George Wells; Maarten Boers
Journal:  Arthritis Rheum       Date:  2009-05-15

5.  Relation of rheumatoid factor and anti-cyclic citrullinated peptide antibody with disease activity in rheumatoid arthritis: cross-sectional study.

Authors:  Jung-Yoon Choe; Jisuk Bae; Hwajeong Lee; Sang-Cheol Bae; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2013-04-04       Impact factor: 2.631

Review 6.  Induction of remission in rheumatoid arthritis: criteria and opportunities.

Authors:  Guido Valesini; Manuela Di Franco; Francesca Romana Spinelli; Rossana Scrivo
Journal:  Rheumatol Int       Date:  2008-09-21       Impact factor: 3.580

7.  Remission makes its way to rheumatology.

Authors:  Tuulikki Sokka; Heidi Mäkinen
Journal:  Arthritis Res Ther       Date:  2010-07-14       Impact factor: 5.156

Review 8.  Applying science in practice: the optimization of biological therapy in rheumatoid arthritis.

Authors:  Sofia Ramiro; Pedro Machado; Jasvinder A Singh; Robert B Landewé; José António P da Silva
Journal:  Arthritis Res Ther       Date:  2010-11-04       Impact factor: 5.156

9.  Time to achieve remission determines time to be in remission.

Authors:  Lydia G Schipper; Jaap Fransen; Alfons A den Broeder; Piet L C M Van Riel
Journal:  Arthritis Res Ther       Date:  2010-05-20       Impact factor: 5.156

Review 10.  Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility.

Authors:  M F Bakker; J W G Jacobs; S M M Verstappen; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 27.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.